Full Paper
1H), 6.42 (t, J=7.8 Hz, 1H), 6.23 (d,
J=7.8 Hz, 1H), 2.47 (s, 3H), 2.39 (s,
3H), 2.02 ppm (s, 3H); 13C NMR
(500 MHz, CDCl3): d=175.7, 143.5,
143.2, 138.8, 132.7, 131.5, 131.3,
129.9, 129.3 (2C), 127.7 (2C), 127.5,
21.7, 4.1, 2.1 ppm; IR (KBr): n˜ =
3420, 3067, 2928, 2321, 2294,
1659, 1552, 1432, 1281, 1251, 933,
841, 746, 661, 579, 550 cmÀ1
HRMS/ESI: m/z calcd for
454.9448
;
C16H14ClN2O3PdS:
[MÀCH3CN+H]+; found: 454.9463.
General procedure B for ortho-al-
koxylation of N-tosylbenzamide
1a–o: In a round bottom flask, N-
tosylbenzamide 1a–o (1 equiv)
was added to a solution of PhI-
(OAc)2 (1 equiv) and [Pd(OAc)2]
Scheme 4. N-methylation and subsequent functional transformations of 3 f.
(0.1 equiv) in MeOH, EtOH, or
iPrOH (8.3 mLmmolÀ1 of 1a–o).
This mixture was stirred at 258C (see Table 2 and Scheme 4 for re-
action times) and monitored by TLC. Upon completion, the result-
ing mixture was diluted with EtOAc, filtered through a pad of
Celite and the solvent was evaporated. The crude residue was puri-
fied by silica gel chromatography using cyclohexane/EtOAc (4:1 to
3:2 gradient) as the eluent to obtain the desired products 3a–q.
reactions and find applications in the synthesis of functional-
ized arenes under mild conditions.
Experimental Section
2-Chloro-6-methoxy-N-(4-methylbenzenesulfonyl)benzenecarboxamide
(3a): Starting from N-tosylbenzamide 1a (0.200 g, 0.65 mmol),
using general procedure B, compound 3a was obtained as a white
solid (0.208 g, 95%). M.p. 140–1428C. 1H NMR (400 MHz, CDCl3):
d=7.97 (d, J=8.3 Hz, 2H), 7.35 (d, J=8.3 Hz, 2H), 7.27 (t, J=
8.3 Hz, 1H), 6.94 (d, J=8.7 Hz, 1H), 6.79 (d, J=8.4 Hz, 1H), 3.76 (s,
3H), 2.45 ppm (s, 3H); the NH signal is missing; 13C NMR (100 MHz,
CDCl3): d=162.4, 157.6, 145.4, 135.5, 132.6, 132.3, 129.7 (2C), 128.8
(2C), 123.1, 122.3, 109.7, 56.3, 21.7 ppm; IR (KBr): n˜ =3198, 3045,
2946, 1691, 1595, 1466, 1272, 1151, 783 cmÀ1; HRMS/ESI: m/z calcd
for C15H14ClNO4SNa: 362.0230 [M+Na]+; found: 362.0212.
Syntheses
General procedure A for the preparation of substituted N-tosyl-
benzamides 1a–o: A round-bottom flask under N2 was filled with
p-toluene sulfonamide (1 equiv), EtOAc (2 mLmmolÀ1), NEt3
(2.5 equiv), and 4-dimethylaminopyridine (DMAP; 0.005 equiv). A
solution of acyl chloride (1.1 equiv) in PhMe (0.8 mLmmolÀ1) was
added through a syringe over 15 min. The mixture was stirred for
1 hour at 558C under N2, cooled to room temperature and
quenched with an aqueous solution of hydrochloric acid (0.5m,
3 mLmmolÀ1). The resulting mixture was then extracted with
EtOAc (3 times). The combined organic layers were dried on
MgSO4, filtered and evaporated. The crude was purified by passing
through a pad of silica gel eluting with CH2Cl2.
General procedure C for ortho-halogenation of N-tosylbenza-
mide 1a,b,f,g using NXS: In a round-bottom flask, N-tosylbenza-
mide 1a,b,f,g (1 equiv) and trifluoroacetic acid (10 equiv) was
added to a solution of NXS (1.2 equiv) and [Pd(OAc)2] (10 mol%) in
MeOH (12.8 mLmmolÀ1 of 1a,b,f,g). The reaction was stirred at
258C (see Tables 3–5 for reaction times). The resulting mixture was
diluted with EtOAc, filtered through a pad of Celite and the solvent
was evaporated. The crude was purified by silica gel chromatogra-
phy using cyclohexane/EtOAc (4:1 to 3:2 gradient) as the eluent to
obtain the desired product 4b or 5a–d or 6a–c.
2-Fluoro-N-(4-methylbenzenesulfonyl)benzenecarboxamide
Starting from 2-fluorobenzoyl chloride (2.43 g, 15.3 mmol), using
(1e):
general procedure A, N-tosylbenzamide 1e was obtained as
a
white solid (3.93 g, 92% yield). M.p. 137–1388C. 1H NMR
(400 MHz, CDCl3): d=9.01 (brs, 1H), 8.05 (d, J=8.4 Hz, 2H), 7.99
(td, J=12.3, 4.0 Hz, 1H), 7.56 (m, 1H), 7.36 (d, J=8.4 Hz, 2H), 7.26
(td, J=7.6, 0.9 Hz, 1H), 7.16 (ddd, J=12.3, 8.4, 0.9 Hz, 1H),
2.44 ppm (s, 3H); 13C NMR (100 MHz, CDCl3): d=161.0 (d, J=
249 Hz), 160.5 (d, J=3 Hz), 145.5, 135.8 (d, J=10 Hz), 135.5, 132.6,
129.8 (2C), 129.0 (2C), 125.5 (d, J=3 Hz), 118.6 (d, J=10 Hz), 116.6
(d, J=25 Hz), 21.8 ppm; IR (KBr): n˜ =3325, 3088, 2923, 1705, 1595,
1428, 1350, 1167, 753 cmÀ1; HRMS/ESI: m/z calcd for C14H13FNO3S:
294.0594 [M+H]+; found: 294.0597.
2-Bromo-6-chloro-N-(4-methylbenzenesulfonyl)benzenecarboxamide
(5a): Starting from N-tosylbenzamide 1a (0.100 g, 0.32 mmol),
using general procedure C with NBS, compound 5a was obtained
1
as a white solid (0.097 g, 77%). M.p. 72–748C; H NMR (400 MHz,
CDCl3): d=7.99 (d, J=8.1 Hz, 2H), 7.42 (d, J=8.0 Hz, 1H), 7.36 (d,
J=8.2 Hz, 2H), 7.30 (d, J=8.1 Hz, 1H), 7.19 (t, J=8.1 Hz, 1H),
2.46 ppm (s, 3H); the NH signal is missing; 13C NMR (100 MHz,
CDCl3): d=162.6, 145.8, 135.4, 134.9, 132.3, 132.2, 131.4, 129.8 (2C),
128.9 (2C), 128.8, 120.1, 21.9 ppm; IR (KBr): n˜ =3216, 3045, 2923,
1712, 1448, 1349, 1170, 1090, 776 cmÀ1; HRMS/ESI: m/z calcd for
C14H12BrClNO3S: 387.9404 [M+H]+; found: 387.9404.
Synthesis of palladacycle 2b: [Pd(OAc)2] (0.229 g, 1.02 mmol) was
added to a solution of 1a (0.300 g, 0.97 mmol) in MeOH (6 mL).
The reaction mixture was stirred at 258C for 18 h. The crude mix-
ture was filtered through a pad of Celite. The Celite pad was
washed with MeOH (25 mL) and the solution was evaporated to
dryness. MeCN (25 mL) was added, the solution was stirred at 258C
for 0.5 h and evaporated to afford palladacycle 2b as a yellow
solid (0.452 g, 94%). M.p.>2508C; 1H NMR (400 MHz, CDCl3): d=
7.95 (d, J=8.3 Hz, 2H), 7.28 (d, J=8.3 Hz, 2H), 6.87 (d, J=7.8 Hz,
General procedure D for ortho-iodination of N-tosylbenzamide
1a,e,f,g,i,m using IOAc: PhI(OAc)2 (0.75 equiv), I2 (0.75 equiv) and
MeOH (12.8 mLmmolÀ1 of 1a,e,f,g,i,m) were added in a round-
bottom flask. The reaction was stirred for 0.25 h at room tempera-
Chem. Eur. J. 2014, 20, 1 – 8
5
ꢁ 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
&
&
These are not the final page numbers! ÞÞ